Skip to main content
Log in

Pharmacokinetics and bioavailability of intravenous and oral chlordesmethyldiazepam in humans

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Six healthy, fasting volunteers were given single doses of chlordesmethyldiazepam by 1 mg i. v., or as drops or tablets. Chlordesmethyldiazepam and its metabolite, lorazepam, in multiple plasma samples and in urine collected for 120 h after each dose were determined by electron-capture GLC.

Mean kinetic variables for intravenous chlordesmethyldiazepam were: volume of distribution, 1.71 l · kg−1; elimination half-life, 113 h; total clearance, 0.21 ml · min−1 · kg−1; cumulative excretion of lorazepam glucuronide 24.2% of the dose.

Following a lag time of 15.5 min (tablets) and 4.2 min (drops), which were significantly different, the absorption of oral chlordesmethyldiazepam was a first order process, with apparent absorption half-life values averaging 1.5 h (tablets) and 1.1 h (drops). Bioavailability was 77% for tablets and 79% for drops.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. De Angelis L, Traversa V, Vertua R (1974) Structure activity relationship within the class of 1,4, benzodiazepines: Presence of chlorine and central nervous system activities. Curr Ther Res 16: 324–337

    Google Scholar 

  2. Traversa U, De Angelis L, Vertua R (1977) On the hypnogenic and anticonvulsant activities of desmethyldiazepam and chlordesmethyldiazepam: Time-effect relations. J Pharm Pharmacol 29: 504–506

    Google Scholar 

  3. Castellani A, Colafelice M, Lorini M, Perbellini D (1979) A single blind, crossover comparison of the anxiolitic activity of chlordesmethyldiazepam: Analysis of single item changes. Clin Ther 2: 343–351

    Google Scholar 

  4. Agricola A, Mazzarino M, Agricola R, Urani R, Fresia P (1981) A double-blind, crossover clinical trial of chlordesmethyldiazepam versus lorazepam in neurotic inpatients: Activity on anxiety-depression symptoms. Clin Ther 4: 339–408

    Google Scholar 

  5. Lanzoni J, Airoldi L, Marcucci F, Mussini E (1979) Gas chromatographic determination of chlordesmethyldiazepam and lorazepam in rats and mice. J Chromatogr 168: 260–265

    Google Scholar 

  6. Dal Bo L, Marcucci F, Mussini E, Perbellini D, Castellani A, Fresia P (1980) Plasma levels of chlordesmethyldiazepam in human. Biopharm Drug Dispos 1: 123–126

    Google Scholar 

  7. Bareggi SR, Pirola R, Leva S, Zecca L (1986) Pharmacokinetics of chlordesmethyldiazepam after single-dose oral administration in humans. Eur J Drug Metabol Pharmacokinet 11: 171–174

    Google Scholar 

  8. Bareggi SR, Nielsen NP, Leva S, Pirola R, Zecca L, Lorini M (1986) Age-related multiple-dose pharmacokinetics and anxiolytic effects of delorazepam (chlordesmethyldiazepam). Int J Clin Pharmacol Res 6: 309–314

    Google Scholar 

  9. Williams TH, Sasso GJ (1979) Novel application of proton nuclear magnetic resonance spectroscopy in the identification of 2-chloronordiazepam in the dog. J Med Chem 22: 436–440

    Google Scholar 

  10. De Silva JAF, Bekersky I, Puglisi CV (1973) The determination of 7-chloro-1,3-dihydro-5-(2,chlorphenyl)-2H-1,4-benzodiazepin-2-one (RO-5-3027) and its metabolite (lorazepam) in blood and urine by electron-capture gas-liquid chromatography. J Chromatogr Sci 11: 547–554

    Google Scholar 

  11. Zecca L, Ferrario P, Pirola R, Bareggi SR (1987) Analysis of chlordesmethyldiazepam and its metabolites in plasma and urine. J Chromatogr Biomed App 420: 417–429

    Google Scholar 

  12. Greenblatt DJ, Franke K, Shader RI (1978) Analysis of lorazepam and its glucuronide metabolite (lorazepam) in blood and urine by electron-capture gasliquid chromatography. Use in pharmacokinetic studies of lorazepam. J Chromatogr 146: 311–320

    Google Scholar 

  13. Sacchi Landriani G, Guardabasso V, Rocchetti M (1983) NLFIT: A microcomputer program for non-linear fitting. Comput Progr Biomed 16: 35–42

    Google Scholar 

  14. Mandelli M, Tognoni G, Garattini S (1978) Clinical pharmacokinetics of diazepam. Clin Pharmacokinet 3: 72–91

    Google Scholar 

  15. MacLeod SM, Giles HM, Patzalek G, Thiessen JJ, Sellers EM (1977) Diazepam actions and plasma concentrations following ethanol ingestion. Eur J Clin Pharmacol 11: 345–349

    Google Scholar 

  16. Greenblatt DJ, Shader RI, Weinberger DR, Allen MD, MacLaughlin DS (1978) Effect of a cocktail on diazepam absorption. Psychopharmacology 57: 199–203

    Google Scholar 

  17. Greenblatt DJ, Shader RI, Franke K, MacLaughlin DS, Harmatz JS, Allen MD, Werner A, Woo E (1979) Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam. J Pharm Sci 68: 57–63

    Google Scholar 

  18. Kaplan SA, Jack ML, Alexander K, Weinfeld RE (1973) Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administration. J Pharm Sci 62: 1789–1804

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bareggi, S.R., Truci, G., Leva, S. et al. Pharmacokinetics and bioavailability of intravenous and oral chlordesmethyldiazepam in humans. Eur J Clin Pharmacol 34, 109–112 (1988). https://doi.org/10.1007/BF01061430

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01061430

Key words

Navigation